Delivery Order SPE2DB22D2211-SPE2DB25FSECZ
- Not listed
- The Defense Logistics Agency awarded a $1,782.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Promethegan 25 mg suppositories (12-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of August 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Promethegan 12.5 mg suppositories (12-count units) with a ceiling value of $1,950.24. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $1,218.96 to AmerisourceBergen Drug Corp for the supply of Promethegan 12.5 mg suppositories (12-count packages). This firm fixed-price delivery order, issued on July 26, 2025, with completion targeted for July 28, 2025, represents a routine pharmaceutical procurement supporting federal medical supply requirements. The award was made through open competition with no set-aside designation, and performance will be executed at the...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,794.40 firm fixed price delivery order to provide PROMETHEGAN 25 MG SUPPOSITORY 12S pharmaceutical products. This order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PROMETHEGAN 25 MG SUPPOSITORY 12S, with a ceiling value of $3,895.80 and a period of performance through June 26, 2025. The contract is not set-aside and was awarded on June 25, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,154.16, is for the delivery of PROMETHEGAN 25 MG SUPPOSITORY 12S medical supplies. It is a firm fixed-price delivery order contract with a completion date of March 31, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,731,440 units of Promethazine 25 mg Suppository, with a ceiling value of $1,294.18. The contract is a Firm Fixed Price Delivery Order with a period of performance ending on March 31, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,256.80 firm-fixed-price delivery order is for the supply of PROMETHEGAN 12.5 MG SUPPOS 12S, a pharmaceutical product. The contract has an ultimate completion date of October 28, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- The Defense Logistics Agency awarded a $17,659.45 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Indomethacin 50 mg suppositories (30-count units), with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $1,063.72 to AmerisourceBergen Drug Corp on August 9, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the prime contractor under its larger indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSECZDelivery Order
The Defense Logistics Agency awarded a $3,376.76 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Promethegan 25 mg suppositories (12-count units). This firm fixed-price contract, which is a child order under a larger indefinite delivery contract vehicle, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen's $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The contract encompasses medications across multiple therapeutic domains, including specialty drugs, brand-name and generic pharmaceuticals, vaccines, and related medical supplies. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains significant capacity to fulfill diverse federal medical supply requirements through competitive contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 9/3/25 |